Get App Open
In App
Credit Cards
Open App
you are here:
Success
Alert
Please select a Day.
Info

Zydus Lifesciences Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

844.40
-14.70 (-1.71%)

As on 09 Apr, 2025 | 03:59

Day Range
823.30
849.85
L H
52 Week Range
795.00
1324.30
L H
Volume
1,594,419
*
i

* BSE Market Depth (09 Apr 2025)

BUY SELL
QTY PRICE PRICE QTY
1 845.05 846.90 10
7 845.00 846.95 5
1 843.60 847.35 18
4 843.50 849.00 10
100 843.40 849.35 250
0 Total Total 0
Bid / Ask
0.00 / 0.00
844.60
-14.95 (-1.74%)

As on 09 Apr, 2025 | 04:01

Day Range
823.95
849.65
L H
52 Week Range
797.05
1323.90
L H
Volume
55,732
*
i

* BSE Market Depth (09 Apr 2025)

BUY SELL
QTY PRICE PRICE QTY
1 845.05 846.90 10
7 845.00 846.95 5
1 843.60 847.35 18
4 843.50 849.00 10
100 843.40 849.35 250
0 Total Total 0
Bid / Ask
0.00 / 0.00
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Bid / Ask
/
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Bid / Ask
/
NSE
MC Essentials
82% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 840.40
          Previous Close 859.10
          Volume 1,594,419.00
          Value (Lacs) 13,463.27
            VWAP 840.69
          Beta
          Mkt Cap (Rs. Cr.) 84,966
          High 849.85
          Low 823.30
          UC Limit 945.00
          LC Limit 773.20
          52 Week High 1,324.30
          52 Week Low 795.00
          Face Value 1.00
          All Time High 1,324.30
          All Time Low 5.53
          20D Avg Volume 2,827,116
          20D Avg Delivery(%) 28.35
          Book Value Per Share 216.89
          Dividend Yield 0.36
          TTM EPS See historical trend 46.46 (+19.16% YoY)
          TTM PE See historical trend 18.17 (Low PE)
          P/B See historical trend 3.90 (Average P/B)
          Sector PE 44.20

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 36.24% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 74.98% in Dec 2024 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          SCANS

          Companies decreasing their Debt to Equity ratio

          Companies that are Improving efficiency in utilising shareholders funds

          Companies increasing efficiency in utilisation of all sources of capital

          Companies that have grown profits and net profit margins over the past 12 months

          Companies that have increased their book values and have low Price to Earnings Ratio

          Scan lists companies in which Promoter holding exceeds 70%

          Powered by: Definedge

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 17 years Zydus Lifesciences has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 29.54% (2021) 10.05% -6.22% (2019) -3.89% 4.31%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Cadila Health

          What's your call on Cadila Health today?

          Read 3 investor views

          BUY SELL HOLD

          Broker Research

          07 Feb, 2025

          KRChoksey

          Reco Price 993.95 Target Price 1201
          06 Feb, 2025

          ICICI Securities

          Reco Price 1008.30 Target Price 1000
          06 Feb, 2025

          Prabhudas Lilladher

          Reco Price 1008.30 Target Price 1050
          13 Nov, 2024

          KRChoksey

          Reco Price 963.60 Target Price 1201
          13 Nov, 2024

          Prabhudas Lilladher

          Reco Price 963.60 Target Price 1050
          03 Oct, 2024

          Sharekhan

          Reco Price 1068.85 Target Price 1268

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          30 Aug, 2024

          Ubs Principal Capital Asia Limited

          Qty 6701664 Price 1128.11 % Traded 0.67

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          29 Mar, 2024

          Zydus Family Trust

          Promoter
          Qty 30000 Price 1010.62 % Traded 0.00 Post Tnx Hold. 74.96%
          29 Mar, 2024

          Zydus Family Trust

          Promoter
          Qty 10000 Price 1006.68 % Traded 0.00 Post Tnx Hold. 74.97%
          29 Mar, 2024

          DEVAL DHIRAJBHAI SHAH

          Employees Immediate Relative
          Qty 292 Price 1005.25 % Traded 0.00 Post Tnx Hold. 0%
          29 Mar, 2024

          DEVAL DHIRAJBHAI SHAH

          Employees Immediate Relative
          Qty 292 Price 1006.64 % Traded 0.00 Post Tnx Hold. 0%
          28 Mar, 2024

          Zydus Family Trust

          Promoter
          Qty 17534 Price 1015.35 % Traded 0.00 Post Tnx Hold. 75.02%
          28 Mar, 2024

          Zydus Family Trust

          Promoter
          Qty 565466 Price 1008.66 % Traded 0.06 Post Tnx Hold. 74.97%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          09 Aug, 2024

          Life Insurance Corporation of India Disposal

          Other
          Qty 20398344 Price 0 % Traded 2.02 Post Tnx Hold. 3.15%
          29 Mar, 2024

          Zydus Family Trust & PACs Disposal

          Promoter
          Qty 40000 Price 0 % Traded 0.00 Post Tnx Hold. 74.96%
          28 Mar, 2024

          Zydus Family Trust & PACs Disposal

          Promoter
          Qty 583000 Price 0 % Traded 0.05 Post Tnx Hold. 74.97%
          02 Sep, 2021

          Life Insurance Corporation of India Acquisition

          Other
          Qty 20497929 Price 0 % Traded 2.00 Post Tnx Hold. 5.09%
          01 Sep, 2021

          Life Insurance Corporation of India Acquisition

          Other
          Qty 664104 Price 0 % Traded 0.06 Post Tnx Hold. 5.03%
          28 Mar, 2018

          Ramanbhai B Patel (HUF) Disposal

          Promoter
          Qty 15000 Price 0 % Traded 0.00 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          Created with Highstock 6.2.014253.114253.114403.514403.515265.215265.217237.417237.419547.419547.4Revenue20202021202220232024010k20k30k
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          Summary

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Zydus Life 844.40 -1.71 84,966.40 18.17 3.89 19.46 -14.63 3,831 19,547 0.04
          Sun Pharma 1,652.20 -2.14 396,418.12 34.64 5.74 15.04 3.10 9,648 48,496 0.04
          Divis Labs 5,386.15 -0.02 142,985.36 69.18 10.42 11.78 41.56 1,600 7,845 0.00
          Cipla 1,415.60 -1.18 114,326.28 22.91 4.03 15.43 -2.39 4,155 25,774 0.01
          Torrent Pharma 3,126.80 -3.69 105,825.12 56.83 14.10 24.15 21.28 1,656 10,727 0.57

          About the Company

          Cadila Healthcare Ltd operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.The company has in-licensing alliances with global multinationals such as Schering AG, Boehringer Ingelheim, Viatris, etc.Their product range includes Formulations that cater to various therapeutic areas such as cardiovascular, gastrointestinal, respiratory, pain management, CNS, anti-infectives, oncology, neurosciences, dermatology and nephrology segments and Consumer product division-brands like Sugar Free, Nutralite and Everyuth.
          {"success":1,"data":{"address":{"address1":"Zydus Corporate Park, Scheme No.63, \nSur","address2":"Khoraj (Gandhinagar), \n,Nr. Vaishnodevi Circle, \n","city":"Ahmedabad","state":"Gujarat","pincode":"382481","telephone1":"079-48040000","telephone2":"079-71800000","fax1":"079-","fax2":"","email":"investor.grievance@zyduscadila.com","web":"http:\/\/www.zyduslife.com"},"management":[{"name":"Pankaj R Patel","designation":"Chairman"},{"name":"Sharvil P Patel","designation":"Managing Director"},{"name":"Ganesh N Nayak","designation":"Executive Director"},{"name":"Bhadresh K Shah","designation":"Independent Director"},{"name":"Mukesh M Patel","designation":"Non Executive Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"506 - 508, 5th Floor, Amaranth Business Complex I ","address2":"Beside Gala Business Center, Nr. St. Xaviers Corne","address3":"Off C. G. Road, Ellisbridge, Navrangpura,","address4":"","telephone":"079-26465179","fax":"079-26465179","email":"ahmedabad@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Ahmedabad","state":"Gujarat","pincode":"380009"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"Yes"}],"details":{"bseId":"532321","nseId":"ZYDUSLIFE","series":"EQ","isinid":"INE010B01027"}}}
          • Registered Office

          • Registrars

          • Management

            • Pankaj R Patel

              Chairman

            • Sharvil P Patel

              Managing Director

            • Ganesh N Nayak

              Executive Director

            • Bhadresh K Shah

              Independent Director

            • Mukesh M Patel

              Non Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              Yes

          • Details

            • BSE:

              532321

            • NSE:

              ZYDUSLIFE

            • Series

              EQ

            • ISIN

              INE010B01027

          1